Partnership with Hobson enhances Vantedge
Medical's consumables platform and broadens the company's technical
capabilities, customer base and geographical footprint
SAN
JOSE, Calif., Aug. 20,
2024 /PRNewswire/ -- Vantedge Medical ("Vantedge"), a
portfolio company of Aterian Investment Partners ("Aterian"), is
pleased to announce the acquisition of Hobson & Motzer, Inc.
("Hobson" or the "Company").
Founded in 1912 and based in Connecticut, Hobson is a manufacturer of
precision medical devices for the global surgical stapler market.
100% of Hobson's sales stream is derived from medical consumables
devices. The Company's facilities are highly automated and house a
broad set of capabilities including progressive stamping, precision
electrochemical machining, coined wire as well as leading tool and
die capabilities. Hobson represents the fifth medical technology
add-on acquisition for Vantedge since 2018.
The acquisition of Hobson further strengthens Vantedge's
position as a nationwide manufacturing partner to blue-chip medical
OEMs and broadens Vantedge's consumable portfolio offering. Since
Aterian's acquisition of Vantedge in May
2018, Vantedge has acquired five medical technology
businesses, established and fully commercialized new production
facilities, completed substantial capital equipment capacity
expansion and significantly invested in human capital throughout
the organization. Vantedge now operates nine facilities across
the United States with more than
1,200 employees.
"It gives me great pleasure to announce the union of Vantedge
Medical and Hobson & Motzer. I have worked with the Hobson
& Motzer team for many years, and they consistently delivered
best-in-class quality, service, value, and innovation. Their depth
and scale of capabilities, backed by over 100 years of experience,
perfectly complements the existing Vantedge capabilities, enhances
the value we bring to the world's leading medical technology
companies, and amplifies the difference we are making in the lives
of patients and their families.", commented Brian King, Vantedge Medical, Chairman &
CEO.
Greg Santorno, Vantedge Medical's
Chief Commercial Officer mentioned, "Our union with Hobson &
Motzer provides an expanded capability set that significantly
increases the value we will deliver to our customers. Providing
additional device content enables supply chain simplification, risk
reduction, collaborative innovation, and accelerated time to
market. The addition of precision progressive die stamping, unique
value-add machining and assembly technologies, and a deep expertise
in the manufacturing of surgical stapler anvils, complements our
existing strengths serving the Robotic Assisted Surgery, Surgical
Instrumentation, Orthopedics, Ophthalmology, Dental, Drug Delivery
and Medical Diagnostics markets."
"As I contemplated transitioning the company to new ownership,
my key requirements were to find a company that shared our
commitment to quality, service and innovation, had deep experience
in the MedTech space and viewed our capabilities as enablers for
growth. Vantedge Medical met these criteria in every way. I look
forward to the continuing legacy of performance and market
leadership, just at a much larger scale.", added Bruce Dworak, President / Owner, Hobson &
Motzer.
"We are excited to share the news about this transaction which
we believe allows Vantedge to take the next significant step in its
strategic development. Vantedge continues to evolve as a
differentiated, scaled and expanding Medical Technology supplier
into the industry's most attractive OEMs across a variety of
manufacturing disciplines and treatment modalities. The human
health technologies that Vantedge serves on behalf of its'
customers change lives for the better, and in certain
circumstances, save them. It is a privilege to wake up every day
and work alongside Vantedge, and through Vantedge, our customers.",
said Brandon Bethea, Co-Founder
& Partner, Aterian Investment Partners.
Weil Gotshal & Manges LLP advised Aterian on the legal
aspects of this transaction.
About Hobson & Motzer, Inc.
Founded in 1912 and headquartered in Durham, Connecticut. Hobson & Motzer is a
manufacturer of tight tolerance consumable medical devices
primarily for the global surgical stapler industry. For decades,
Hobson has been partnered with leading medical device
manufacturers. The Company's core capabilities include CNC
machining, stamping, tooling and other finishing and assembly
services.
For more information, please visit
https://www.hobsonmotzer.com/.
About Vantedge Medical
Headquartered in San Jose,
California, Vantedge Medical specializes in providing
manufacturing solutions to its customers operating in high growth
and dynamic end markets. Vantedge Medical has been serving its
customers for over 40 years and provides prototyping and
development support, followed by complex manufacturing adhering to
the highest quality standards.
For more information, please visit
https://vantedgemedical.com/
About Aterian Investment Partners
Aterian Investment Partners is a private equity firm that
invests in industry-leading, middle market businesses. In
collaboration with management, Aterian supports investments
throughout an organization, from people to processes, equipment,
technology, and social governance, among others. With offices in
New York and Miami, Aterian has raised cumulative equity
commitments of more than $2 billion
since its founding in 2009
For more information, please visit
http://www.aterianpartners.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vantedge-medical-completes-strategic-acquisition-of-hobson--motzer-302226362.html
SOURCE Aterian Investment Partners